Neova Serious Clarity 4X
Neova Serious Clarity 4X targets hyperpigmentation with a combination of four active ingredients. Dramatically reverses the appearance of dark spots and skin, discolorations.due to sun damage, hormonal changes and post-acne scarring.
Clinical Evaluation of [UDP]* Results in just 8 weeks:
- Visibly evens skin tone and complexion.
- The skin was visibly clearer.
- There were significant increases in even skin tone.
- The skin was significantly lightened.
- The hyperpigmented areas were visibly and significantly lightened.
Works on Dark Spots with 4X the Fading Power.
- U Phenylalanine [UDP]
- Manganese Tripeptide-1 Complex
- Glycyrrhiza Glabra [Licorice] Root Extract
- Tetrahexyldecyl Ascorbate
Key Ingredients To Help Brighten Skin:
U Phenylalanine [UPH] - An essential amino acid directly involved provides a unique mode of action that prevents hyperpigmentation helps lightens the appearance of age spots
*Manganese Tripeptide-1 Complex - A non-toxic inhibitor of melanin promotes even skin tone.
Glycyrrhiza Glabra [Licorice] Root Extract - Inhibits tyrosinase activity and provides effective soothing properties.
Tetrahexyldecyl Ascorbate - Possesses the lightening effects of ascorbic acid with improved skin penetration and less irritation.
Sodium Hyaluronate - A powerful humectant, deeply hydrates and provides an immediate moisturizing boost.
Phellodendron Amurense Bark Extract - Reduces transepidermal water loss [TEWL] and helps to moisturize and calm the skin.
Santalum Album [Sandalwood] Extract - Provides antioxidant properties.
This study evaluated the effects of a manganese peptide complex in the treatment of various signs of cutaneous facial photodamage. Individuals used a facial serum formulation containing the manganese peptide complex Manganese Tripeptide-1 twice a day for up to 12 weeks. At the end of the treatment period, the individuals and a blinded investigator noted improvement in the appearance of several signs of cutaneous photodamage. Predominant among the parameters showing improvement were those associated with hyperpigmentation. In general, at the end of 12 weeks of treatment, photodamage ranking moved from moderate to mild. Treatment was well tolerated with no significant cutaneous inflammation induced by the manganese peptide complex.